{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:06Z","timestamp":1792801746080,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.09.036","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T11:26:22Z","timestamp":1316690782000},"page":"9702-9710","source":"Crossref","is-referenced-by-count":53,"title":["Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness"],"prefix":"10.1016","volume":"29","author":[{"given":"Melissa C.","family":"Whiteman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Wicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Y.-H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (8)","key":"10.1016\/j.vaccine.2011.09.036_bib0005","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/521911","article-title":"The continuing spread of West Nile virus in the western hemisphere","volume":"45","author":"Gubler","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.09.036_bib0010","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/JVI.01963-10","article-title":"Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas","volume":"85","author":"May","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.09.036_bib0015","series-title":"The arboviruses: epidemiology and ecology","first-page":"59","article-title":"West Nile fever","author":"Hayes","year":"1989"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.09.036_bib0020","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","article-title":"Virology, pathology, and clinical manifestations of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.09.036_bib0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-141-5-200409070-00010","article-title":"Clinical characteristics and functional outcomes of West Nile fever","volume":"141","author":"Watson","year":"2004","journal-title":"Ann Intern Med"},{"issue":"May (11)","key":"10.1016\/j.vaccine.2011.09.036_bib0030","first-page":"1399","article-title":"West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario","volume":"168","author":"Pepperell","year":"2003","journal-title":"CMAJ"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.09.036_bib0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3201\/eid0907.030129","article-title":"Acute flaccid paralysis and West Nile virus infection","volume":"9","author":"Sejvar","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2011.09.036_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jama.290.4.511","article-title":"Neurologic manifestations and outcome of West Nile virus infection","volume":"290","author":"Sejvar","year":"2003","journal-title":"JAMA"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.09.036_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/01.WNL.0000073617.08185.0A","article-title":"West Nile virus infection: a new acute paralytic illness","volume":"61","author":"Jeha","year":"2003","journal-title":"Neurology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.09.036_bib0050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.10575","article-title":"Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection","volume":"53","author":"Li","year":"2003","journal-title":"Ann Neurol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.09.036_bib0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1474-4422(07)70030-3","article-title":"West Nile virus","volume":"6","author":"Kramer","year":"2007","journal-title":"Lancet Neurol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.036_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.036_bib0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile virus: a new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu Rev Microbiol"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2011.09.036_bib0070","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.vaccine.2009.10.112","article-title":"Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus","volume":"28","author":"Whiteman","year":"2010","journal-title":"Vaccine"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.09.036_bib0075","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1128\/JVI.79.13.8339-8347.2005","article-title":"Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains","volume":"79","author":"Beasley","year":"2005","journal-title":"J Virol"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.09.036_bib0080","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1099\/vir.0.82299-0","article-title":"Avian virulence and thermostable replication of the North American strain of West Nile virus","volume":"87","author":"Kinney","year":"2006","journal-title":"J Gen Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.09.036_bib0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/viro.1997.8500","article-title":"Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53","volume":"230","author":"Kinney","year":"1997","journal-title":"Virology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.09.036_bib0090","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.42.6.2759-2765.2004","article-title":"Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection","volume":"42","author":"Beasley","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.09.036_bib0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2008.04.165","article-title":"Identification of human hnRNP C1\/C2 as a dengue virus NS1-interacting protein","volume":"372","author":"Noisakran","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.036_bib0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/088282403322396082","article-title":"Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus","volume":"16","author":"Diamond","year":"2003","journal-title":"Viral Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.09.036_bib0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1537-2995.2006.00769.x","article-title":"Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion","volume":"46","author":"Rios","year":"2006","journal-title":"Transfusion"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.036_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-46-1-1","article-title":"The in vivo differentiation of strains of yellow fever virus in mice","volume":"46","author":"Fitzgeorge","year":"1980","journal-title":"J Gen Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.09.036_bib0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00705-004-0430-8","article-title":"Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses","volume":"150","author":"Crabtree","year":"2005","journal-title":"Arch Virol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.09.036_bib0120","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1128\/JVI.67.8.4956-4963.1993","article-title":"Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice","volume":"67","author":"Pletnev","year":"1993","journal-title":"J Virol"},{"issue":"September (Pt 9)","key":"10.1016\/j.vaccine.2011.09.036_bib0125","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1099\/0022-1317-82-9-2251","article-title":"Determination of the intramolecular disulfide bond arrangement and biochemical identification of the glycosylation sites of the nonstructural protein NS1 of Murray Valley encephalitis virus","volume":"82","author":"Blitvich","year":"2001","journal-title":"J Gen Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.09.036_bib0130","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/JVI.73.7.6104-6110.1999","article-title":"Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion","volume":"73","author":"Flamand","year":"1999","journal-title":"J Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.09.036_bib0135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0042-6822(89)90161-X","article-title":"Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells","volume":"169","author":"Mason","year":"1989","journal-title":"Virology"},{"issue":"March (Pt 3)","key":"10.1016\/j.vaccine.2011.09.036_bib0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1099\/0022-1317-71-3-593","article-title":"Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody","volume":"71","author":"Schlesinger","year":"1990","journal-title":"J Gen Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.036_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0042-6822(88)90408-4","article-title":"Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer","volume":"162","author":"Winkler","year":"1988","journal-title":"Virology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.09.036_bib0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0042-6822(89)90544-8","article-title":"Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization","volume":"171","author":"Winkler","year":"1989","journal-title":"Virology"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.09.036_bib0155","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1099\/0022-1317-75-12-3453","article-title":"The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell","volume":"75","author":"Crooks","year":"1994","journal-title":"J Gen Virol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.09.036_bib0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.qco.0000244047.31135.fa","article-title":"Immunopathological mechanisms in dengue and dengue hemorrhagic fever","volume":"19","author":"Green","year":"2006","journal-title":"Curr Opin Infect Dis"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2011.09.036_bib0165","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/343813","article-title":"High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever","volume":"186","author":"Libraty","year":"2002","journal-title":"J Infect Dis"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.09.036_bib0170","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1073\/pnas.1017338108","article-title":"Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein","volume":"108","author":"Gutsche","year":"2011","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T13:45:16Z","timestamp":1593006316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":34,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0264410X11014423"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}